Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.38 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17628753 | 1.00 | ACE (0.43) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL417582 | 1.00 | ACE (0.43) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL1188709 | 0.97 | EPHX1 (0.44) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL11922662 | 0.97 | EPHX1 (0.44) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL31323959 | 0.97 | EPHX1 (0.44) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL1595664 | 0.97 | EPHX1 (0.44) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| Cyclohexane SCHEMBL18344237 | 0.97 | EPHX1 (0.44) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL2055541 | 0.97 | EPHX1 (0.44) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| SCHEMBL29234882 | 0.97 | ACE (0.42) | ACEALDH1A1SMN1; SMN2EPHX1CA12 | |
| Hydrochloric Acid SCHEMBL5741895 | 0.97 | ACE (0.42) | ACEALDH1A1SMN1; SMN2EPHX1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 45766 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4161557-B1 | WS-635 FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION | WATERSTONE PHARMACEUTICALS WUHAN CO LTD (CN) | 2026-03-11 | — | — | EP | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4461734-B1 | TYK2 INHIBITORS AND USES THEREOF | ALUMIS INC (US) | 2026-02-04 | — | — | EP | claimed |
| EP-4480953-B1 | TYK2 INHIBITORS AND USES THEREOF | ALUMIS INC (US) | 2026-02-04 | — | — | EP | claimed |
| US-12503449-B2 | Methods of preparing chiral benzodiazepinone derivatives | IMMUNOME, INC. (US) | 2025-12-23 | — | — | US | claimed |
| US-20250327070-A1 | COMPOSITIONS AND METHODS FOR INHIBITING COMPLEMENT FACTOR B | AstraZeneca Ireland Limited (IE) | 2025-10-23 | — | — | US | claimed |
| US-20250281566-A1 | EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF | PRONEUROGEN INC (US) | 2025-09-11 | — | — | US | claimed |
| US-12358863-B2 | Nitrogen-containing derivative of substituted phenol hydroxy acid ester, and preparation and use thereof | WEST CHINA HOSPITAL, SICHUAN UNIVERSITY (CN) | 2025-07-15 | — | — | US | claimed |
| US-20250197414-A1 | SALT FORM AND CRYSTAL FORM OF VANIN ENZYME INHIBITOR, METHOD FOR PREPARING SAME, AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. (CN) | 2025-06-19 | — | — | US | claimed |
| CN-112154151-B | Treatment or prevention of coronaviridae infections | 中美华世通生物医药科技(武汉)股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-1204649-A | Naloxonate and naltrexonate and series product and preparation method | LU ZHENGTANG (CN) | 1999-01-13 | — | — | CN | claimed |
| EP-0799041-A1 | ESTROGEN COMPOSITIONS AND METHOD FOR NEUROPROTECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 1997-10-08 | — | — | EP | claimed |
| US-5559256-A | Aminediol protease inhibitors | E. R. SQUIBB & SONS, INC. (US) | 1996-09-24 | — | — | US | claimed |
| US-5554601-A | ADMINISTERING AN ESTROGEN COMPOUND IN THE ABSENCE OF TESTOSTERONE; TREATMENT OF ALZHEIMER*S | UNIVERSITY OF FLORIDA (US) | 1996-09-10 | — | — | US | claimed |
| WO-1995012402-A1 | ESTROGEN COMPOSITIONS AND METHOD FOR NEUROPROTECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 1995-05-11 | — | — | WO | claimed |
| EP-0307135-B1 | 17-SUBSTITUTED ANDROSTA-1,4-DIEN-3-ONE DERIVATIVES | FARMITALIA CARLO ERBA S.r.l. (IT) | 1992-08-19 | — | — | EP | claimed |
| US-4256745-A | OXYTOCICS; DURABILITY | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | claimed |
| US-4196204-A | ANTIANDROGENS, ACNE, SEBORRHEA | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | claimed |
| US-4089865-A | Certain thiazole compounds | SYNTEX (U.S.A.) INC. (US) | 1978-05-16 | — | — | US | claimed |
| US-3933903-A | Process for the preparation of cycloalkylalkane carboxylic acid | AKZO N.V. (NL) | 1976-01-20 | — | — | US | claimed |